Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Tenet Healthcare ( (THC) ).
On November 21, 2025, Stephen H. Rusckowski resigned from Tenet Healthcare Corporation’s board of directors, prompting the board to reduce its size from thirteen to twelve members.
The most recent analyst rating on (THC) stock is a Buy with a $240.00 price target. To see the full list of analyst forecasts on Tenet Healthcare stock, see the THC Stock Forecast page.
Spark’s Take on THC Stock
According to Spark, TipRanks’ AI Analyst, THC is a Outperform.
Tenet Healthcare’s overall stock score is driven by strong financial performance and positive earnings call outcomes, indicating robust growth and improved financial stability. However, technical analysis shows bearish momentum, which could pose short-term challenges. The stock’s undervaluation presents an opportunity for long-term investors, despite potential policy-related risks.
To see Spark’s full report on THC stock, click here.
More about Tenet Healthcare
Average Trading Volume: 1,073,568
Technical Sentiment Signal: Buy
Current Market Cap: $16.87B
For an in-depth examination of THC stock, go to TipRanks’ Overview page.